A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality-Reference-Cited by-同舟云学术

A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality

Published:2022-05 Issue: Volume:Volume 14 Page:203-217
ISSN:2253-2447
Container-title:Research and Reports in Urology
language:en
Short-container-title:RRU

Author:

Söderdahl Fabian,Xu Li-Di,Bring Johan,Häggman Michael^ORCID

Publisher

Informa UK Limited

Subject

Urology

Reference45 articles.

1. European Cancer Information System. European Union; 2021. Available from: https://ecis.jrc.ec.europa.eu. Accessed October 25, 2021.

2. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths

3. European Association of Urology. EAU guidelines; 2021. Available from: http://uroweb.org/guidelines/compilations-of-all-guidelines/. Accessed December 6, 2021.

4. Schaeffer E, Srinivas S, Antonarakis ES, et al. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. J Natl Compr Canc Netw. 2021;19(2):134-143. doi:10.6004/jnccn.2021.0008

5. Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the prognostic value of a three‐gene signature and clinical parameters‐based risk score in prostate cancer patients;The Prostate;2023-06-08

2. P‐score in preoperative biopsies accurately predicts P‐score in final pathology at radical prostatectomy in patients with localized prostate cancer;The Prostate;2023-03-20

3. Correlation Between Long-Term Acetylsalicylic Acid Use and Prostate Cancer Screening with PSA. Should We Reduce the PSA Cut-off for Patients in Chronic Therapy? A Multicenter Study;Research and Reports in Urology;2022-10